Contributed Abstracts
Hall 1 (Salt Palace Convention Center)
BI-Specific T CELL Therapy for Pancreatic Cancer
Usanarat Anurathapan, MD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Robert C Chan, MD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Hakeem F. Hindi, BA, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Roopa Mucharla, MSc, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Helen E. Heslop, MD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Cliona M. Rooney, PhD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Malcolm K. Brenner, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Ann M Leen, PhD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Juan F. Vera, MD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital
Peri-Transplant Toxicity for Pediatric Patients with High-Risk Medulloblastoma Undergoing Tandem Autologous Hematopoietic Cell Transplantation
Menachem Bitan, MD, PhD, Tel-Aviv Sourasky Medical Center;
Rina Dvir, MD, Tel-Aviv Sourasky Medical Center;
Rozalin Furer, RN, Tel-Aviv Sourasky Medical Center;
Shlomi Constantini, MD, MSc, Tel-Aviv Sourasky Medical Center;
Ronit Elhasid, MD, Tel-Aviv Sourasky Medical Center
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Sunitha Kakarla, Baylor College of Medicine;
Kevin Chow, Baylor College of Medicine;
Melinda Mata, Baylor College of Medicine;
Xiao-Tong Song, Baylor College of Medicine;
Men-Feng Wu, Baylor College of Medicine;
Hao Liu, Baylor College of Medicine;
Lisa Wang, Baylor College of Medicine;
David Rowley, Baylor College of Medicine;
Klaus Pfizenmaier, University of Stuttgart;
Stephen Gottschalk, Baylor College of Medicine